Chemed Co. (NYSE:CHE) VP Michael D. Witzeman Sells 2,174 Shares

Share on StockTwits

Chemed Co. (NYSE:CHE) VP Michael D. Witzeman sold 2,174 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $430.00, for a total value of $934,820.00. Following the completion of the transaction, the vice president now directly owns 5,175 shares in the company, valued at $2,225,250. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Shares of NYSE CHE opened at $436.18 on Thursday. The company has a quick ratio of 0.78, a current ratio of 0.81 and a debt-to-equity ratio of 0.25. The business’s 50 day moving average is $396.70 and its two-hundred day moving average is $345.80. The company has a market cap of $6.85 billion, a P/E ratio of 36.56, a P/E/G ratio of 2.93 and a beta of 1.14. Chemed Co. has a 12 month low of $260.03 and a 12 month high of $441.48.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Thursday, July 25th. The company reported $3.36 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.09 by $0.27. The company had revenue of $473.60 million for the quarter, compared to the consensus estimate of $471.72 million. Chemed had a return on equity of 35.63% and a net margin of 10.94%. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the business posted $2.81 EPS. Sell-side analysts expect that Chemed Co. will post 13.54 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 3rd. Shareholders of record on Monday, August 12th will be given a $0.32 dividend. This is an increase from Chemed’s previous quarterly dividend of $0.30. This represents a $1.28 annualized dividend and a yield of 0.29%. The ex-dividend date is Friday, August 9th. Chemed’s payout ratio is currently 10.73%.

A number of research analysts recently weighed in on the company. Royal Bank of Canada raised their price objective on Chemed to $405.00 and gave the company a “sector perform” rating in a research note on Monday, July 29th. ValuEngine raised Chemed from a “hold” rating to a “buy” rating in a research note on Friday, June 7th. Oppenheimer raised their price objective on Chemed from $400.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. Finally, Zacks Investment Research downgraded Chemed from a “hold” rating to a “sell” rating in a research note on Thursday, May 9th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. Chemed has an average rating of “Hold” and an average price target of $383.75.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Cresset Asset Management LLC grew its holdings in shares of Chemed by 9.6% during the 2nd quarter. Cresset Asset Management LLC now owns 1,541 shares of the company’s stock worth $556,000 after purchasing an additional 135 shares in the last quarter. Vestmark Advisory Solutions Inc. acquired a new stake in Chemed in the 2nd quarter valued at $236,000. Harvest Fund Management Co. Ltd boosted its stake in Chemed by 152.9% in the 2nd quarter. Harvest Fund Management Co. Ltd now owns 177 shares of the company’s stock valued at $64,000 after buying an additional 107 shares in the last quarter. Prudential PLC boosted its stake in Chemed by 27.3% in the 2nd quarter. Prudential PLC now owns 1,400 shares of the company’s stock valued at $505,000 after buying an additional 300 shares in the last quarter. Finally, Royal Bank of Canada boosted its stake in Chemed by 46.3% in the 2nd quarter. Royal Bank of Canada now owns 21,807 shares of the company’s stock valued at $7,868,000 after buying an additional 6,906 shares in the last quarter. 87.14% of the stock is currently owned by institutional investors.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

See Also: What is the Gross Domestic Product (GDP)?

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

VANGUARD SCOTTS/VANGUARD RUSSELL 20  Shares Acquired by Wells Fargo & Company MN
VANGUARD SCOTTS/VANGUARD RUSSELL 20 Shares Acquired by Wells Fargo & Company MN
$1.41 EPS Expected for Burlington Stores Inc  This Quarter
$1.41 EPS Expected for Burlington Stores Inc This Quarter
$1.79 Billion in Sales Expected for Burlington Stores Inc  This Quarter
$1.79 Billion in Sales Expected for Burlington Stores Inc This Quarter
Public Employees Retirement System of Ohio Has $2.94 Million Holdings in Wyndham Destinations
Public Employees Retirement System of Ohio Has $2.94 Million Holdings in Wyndham Destinations
Public Employees Retirement System of Ohio Buys Shares of 34,182 Guardant Health Inc
Public Employees Retirement System of Ohio Buys Shares of 34,182 Guardant Health Inc
Public Employees Retirement System of Ohio Grows Position in Empire State Realty Trust Inc
Public Employees Retirement System of Ohio Grows Position in Empire State Realty Trust Inc


© 2006-2019 Ticker Report